Michal Abrahamowicz

Research Scientist, PhD



  • James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
  • Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre 

Research Interests

  • Biostatistics
  • Survival analysis
  • Pharmacoepidemiology
  • Clinical epidemiology
  • Epidemiologic methods
  • Longitudinal analysis
  • Non-communicable disease epidemiology

Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.

Learn more

His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).

Recent News Coverage

September is Arthritis Awareness Month

September is Arthritis Awareness Month Arthritis Research Canada has launched a month-long campaign to create awareness about the most costly chronic disease in this country: arthritis. There are over 100 different forms of arthritis. It impacts six...

I’m Spencer O’Brien, Ask Me Anything

I'm Spencer O'Brien, Ask Me Anything Do you have questions about what it’s like to live with rheumatoid arthritis at a young age? Would you like a Team Canada Olympic snowboarder with RA to answer your questions? Our Reddit AMA with Spencer O'Brien is now...

What you need to know about biosimilars

What you need to know about biosimilars On May 27, British Columbia became the first province to expand the use of biosimilars/biogenerics. Find out what this means for the more than 800,000 people in BC living with arthritis.To read our frequently asked...

Arthritis Research Canada opens fourth centre

Arthritis Research Canada opens fourth centre Arthritis Research Canada, the largest clinical arthritis research institution in North America, continues to grow with its newest centre located at McGill University.  Drs. Deborah Da Costa, Michal...

Arthritis Research Canada graced by talk of Olympic proportions

Arthritis Research Canada graced by talk of Olympic proportions On June 28, Nancy Greene Raine, Canada’s Female Athlete of the 20th Century, joined staff and scientists as Arthritis Research Canada’s Distinguished Guest Speaker for the organization’s...

Living with arthritis? Learn about biosimilars

Living with arthritis? Learn about biosimilars What is a biosimilar/biogeneric? Biologics are medicines taken by IV or self-injection and are made up of large protein molecules derived from living cells. There are now two versions of biologics:...